Company intelligence / Profile preview
Nested Therapeutics
Cambridge, Massachusetts, United Statesnestedtx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Nested Therapeutics is advancing multiple programs including its lead program NST-628 which is in Phase 1 clinical trials for glioma. The company is developing precision oncology treatments with a focus on targeting cancer genes through innovative strategies.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMolecular glue
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Inductive Bio
Beyond the preview
Go deeper on Nested Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nested Therapeutics.